phases

desc-ription

type

250×4.0

250×4.6

250×10  

amide type

oa-2000

(r)-phenylglycine3,5-dinitrobenzoic acid

covalent

1751

1752

1754

oa-2000-i

(r)-phenylglycine3,5-dinitrobenzoic acid

ionic

1757

1758

1760

oa-2200

(r)-phenylglycine(1r, 3r)-chrysanthemic acid

covalent

1763

1764

—

0a-2500

(r)-1-naphthylglycine3,5-dinitrobenzoic acid

covalent

1835

1836

1838

0a-2500-i

(r)-1-naphthylglycine3,5-dinitrobenzoic acid

ionic

1847

1848

1850

urea type

0a-3100

(s)-valine3,5-dinitroanaline

covalent

1769

1770

1772

0a-3200

(s)-tert-leucine3,5-dinitroanaline

covalent

1775

1776

—

0a-3300

(r)-phenylglycine3,5-dinitroanaline

covalent

1781

1782

1784

0a-4000

(s)-valine(s)-1-(α_-naphthyl)-ethylamine

covalent

1787

1788

—

0a-4100

(s)-valine(r)-1-(α_-naphthyl)-ethylamine

covalent

1793

1794

1796

0a-4400

(s)-proline(s)-1-(α_-naphthyl)-ethylamine

covalent

1799

1800

—

0a-4500

(s)-proline(r)-1-(α_-naphthyl)-ethylamine

covalent

1805

1806

1808

0a-4600

(s)-tert-leucine(s)-1-(α_-naphthyl)-ethylamine

covalent

1811

1812

—

0a-4700

(s)-tert-leucine(r)-1-(α_-naphthyl)-ethylamine

covalent

1817

1818

1820

0a-4800

(s)-indoline-2-carboxylic acid(s)-1-(α_-naphthyl)ethylamine

covalent

1823

1824

—

0a-4900

(s)-indoline-2-carboxylic acid(r)-1-(α_-naphthyl)ethylamine

covalent

1829

1830

1832

ligand exchang type

0a-5000

(d)-penicillamine

lec

1859

—

0a-5500

chiral schiff base

lec

1861

—

0a-6100

(l)-tartaric acid-mono-(l)-valine-(s)-1-(_-naphthyl)ethylamide

lec

1863

—

host-guest type

0a-7000

β-cyclodextrin (derivatized)

cavity

—

5649

0a-8000

crown ether

cavity

7050